Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    15502972 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of D-Cycloserine in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Drug: Placebo
2 Completed Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine
3 Enrolling by invitation Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
Conditions: Schizophrenia;   Bipolar Disorder
Interventions: Drug: D-cycloserine;   Drug: placebo
4 Completed A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine

Study has passed its completion date and status has not been verified in more than two years.